Recurrent Pancreatic Carcinoma Completed Phase 1 Trials for RG-4733 (DB11870)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01131234Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsTreatment